Health

Acceleration in Clinical Development! Leads Biolabs' LBL-034 Dosed First Patient in Phase Ⅱ Trial

NANJING, China, Aug. 25, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the first patient has been successfully dosed in the Phase Ⅱ trial of LBL-034 (GPRC5D/CD3 BsAb) following strong Phase Ⅰ data.This milestone endows...

2025-08-25 18:27 1726

Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer

SHANGHAI, Aug. 25, 2025 /PRNewswire/ -- Pulnovo Medical, a global leader in mechanism-driven therapies for Pulmonary Hypertension (PH) and Heart Failure (HF), today announced the appointment ofFrancis Duhay, MD, MBA, FACS as Global Chief Medical Officer. Dr. Duhay, a board-certified General and ...

2025-08-25 16:42 1595

Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy

* The full results of the open label extension (OLE) of the Phase 1b/2a PACIFIC trial investigating bexicaserin for the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs), will be presented for the first time at the International Epilepsy Annual Congress1 * DEEs ar...

2025-08-25 15:43 1189

Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints

HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) ("Akeso" or "the Company") today announced positive results from its Phase 3 clinical trial of gumokimab (AK111), a novel, fully human anti-IL-17A monoclonal antibody, for the treatment of active ankylosing spondylitis (AS). The study ...

2025-08-25 13:46 1304

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

EAST RUTHERFORD, N.J., Aug. 25, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility inWaltham, Massachusetts to fur...

2025-08-25 12:01 1462

Manulife Hong Kong and Macau Strengthens Leadership Team to Advance Health, Product, and Strategy

HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Manulife Hong Kong and Macau are pleased to announce three senior leadership appointments that underscore its commitment to executing strategic priorities and accelerating business growth. Danny Lee has been named Chief Health Officer, KC Cheung as Chief Pr...

2025-08-25 12:00 1925

Harbour BioMed Appoints Yajie Li as Chief Medical Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 24, 2025 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the appointment...

2025-08-25 09:00 1888

Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer

SAN FRANCISCO and SUZHOU, China, Aug. 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing and commercializing high-quality medicines in oncology, cardiovascular and metabolic diseases, autoimm...

2025-08-25 08:00 1758

MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MH WELLNESS FAIR 2025, CHAMPIONING HEALTHY YOUTHS

KUALA LUMPUR, Malaysia, Aug. 23, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) today launches the first edition of its MH Wellness Fair 2025 series, themed "Young & Healthy Champions", in conjunction with the United Nations' International Youth Day that is celebrated every 12...

2025-08-23 17:46 6502

WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES

RENO, Nev., Aug. 22, 2025 /PRNewswire/ -- Winvest Group Limited (OTCQB: WNLV) ("Winvest"), an investment holding company with diverse media, entertainment, and technology portfolios, is pleased to announced that its subsidiary IQI Media Inc. has partnered with BioCalth International Inc., a world...

2025-08-22 20:00 3217

Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform

* The Phase I/II CLINCH study of ATG-022 (CLDN18.2 antibody-drug conjugate) demonstrated promising results, showing robust clinical efficacy and a favorable safety profile in patients with gastric/gastroesophageal junction adenocarcinoma across high, low, and ultra-low CLDN18.2 expression level...

2025-08-22 18:14 2501

Angel Yeast Cup Finals and Industry Development Conference Concludes

Engaging the World Through Fermented Flour-Based Foods SHANGHAI, Aug. 22, 2025 /PRNewswire/ -- The Finals of the 8th Angel Yeast Cup Chinese Fermented Dim Sum Contest and the 12th Fermented Flour-Based Food Industry Development Conference wrapped up in Ningxiang,Hunan province, a region widely r...

2025-08-22 18:04 2519

Heartbeats Launches Digital Wellness Platform Led by World-Renowned Heart Specialist Dr. Hosen Kiat

SYDNEY, Aug. 22, 2025 /PRNewswire/ -- In an online world awash with wellness fads and misinformation, one of the world's most cited cardiologists has decided to step in.Dr Hosen Kiat , ranked among the top 1% of clinical researchers worldwide, has launched aYouTube

2025-08-22 13:22 2016

MALAYSIA SHOWCASES HEALTHCARE EXCELLENCE IN CAMBODIA, DRIVING MOMENTUM TOWARDS MYMT 2026

KUALA LUMPUR, Malaysia, Aug. 22, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) proudly presents Malaysia Healthcare Week 2025 inPhnom Penh, Cambodia, an initiative designed to strengthening healthcare ties between the two nations and positionMalaysia as the medical tourism de...

2025-08-22 11:00 2763

Biosyngen Unveils Innovative Strategies for Next-Generation TIL Therapies in Asia Bio 2025 Singapore

SINGAPORE, Aug. 22, 2025 /PRNewswire/ -- Asia Bio Innovation Summit 2025 is one of the premier industry-focused events inAsia and focus on the hottest topics of ADC and CGT. Asia Bio Innovation summit 2025 Singapore brought together 30+ world-class Speakers, 10+ Exhibitors and 200+ Attendees from...

2025-08-22 09:55 2859

Orange Biomed Lands on Fortune Korea's Top 40 with Portable Diabetes Test

SEATTLE, Aug. 21, 2025 /PRNewswire/ -- Orange Biomed, developer of the world's first pocket-sized A1C testing device, is receiving international recognition for its breakthrough microfluidic technology designed to enhance accessibility and accuracy in chronic disease management. The company has b...

2025-08-22 00:00 1647

Doceree launches Premium Programmatic adding more context, more reach, and more formats to traditional HCP programmatic

* With Premium Programmatic, pharma marketers can now engage physicians across 2,000+ integrated specialist medical platforms delivering clinically aligned content at scale with unmatched precision and exclusive formats. SHORT HILLS, N.J., Aug. 21, 2025 /PRNewswire/ -- Doceree, the only AI-powe...

2025-08-21 21:32 2187

ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment

Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. JENA, Germany, Aug. 21, 2025 /PRNewswire/ -- ZEISS Medical Technology today announced CE mark approval forCIRRUS® PathFinder™, an in...

2025-08-21 20:00 2771

SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

* Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to Korea. * Both reviews expanded cooperation, including next-generation preventive medicines. SEONGNAM, South Korea, Aug. 21, 2025 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biot...

2025-08-21 20:00 1712

BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization

* Bevacizumab Injection officially approved by Indonesia's National Agency of Drug and Food Control (BPOM), following Nigeria, Pakistan, and Colombia – accelerating global commercialization * Approval in ASEAN's largest pharma market strengthens BioDlink's position as a global supplier of ant...

2025-08-21 20:00 1537
1 ... 59606162636465 ... 873

Week's Top Stories